PERLMAN ANDREW J bought RCUS
June 11, 2026 · Form 4 insider transaction
PERLMAN ANDREW J bought 16,900 shares of Arcus Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,900
Price
$0.00
Total value
N/A
InsiderPERLMAN ANDREW J
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 12, 2026
Shares owned after16,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.